MDCX 8-K: Material agreement
Medicus Pharma
Filed with the SEC on · accession 0001062993-26-006043
MDCX filed a 8-K (current report) with the SEC on Nov 16, 2026. Medicus Pharma entered into an exchange agreement with Streeterville Capital to exchange $10.5 million of its Secured Promissory Note A-1 for 105,000 non-convertible, non-voting preferred shares, reducing its debt.
Summary of the filing
Medicus Pharma entered into an exchange agreement with Streeterville Capital to exchange $10.5 million of its Secured Promissory Note A-1 for 105,000 non-convertible, non-voting preferred shares, reducing its debt. The company also closed a registered direct offering of common shares and pre-funded warrants for gross proceeds of approximately $3.0 million.
Key details
✦ Ask GOAX AI about this filing — what it means for MDCX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MDCX?
Click hereFrequently asked questions
What did MDCX file with the SEC on Nov 16, 2026?
MDCX filed a 8-K (Material agreement). Medicus Pharma entered into an exchange agreement with Streeterville Capital to exchange $10.5 million of its Secured Promissory Note A-1 for 105,000 non-convertible, non-voting preferred shares, reducing its debt. The company also closed a registered direct offering of common shares and pre-funded warrants for gross proceeds of approximately $3.0 million.
What does a material agreement mean for MDCX stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other MDCX SEC filings
- 424B5 · Secondary offeringNov 16, 2026
- 10-Q · SEC filingNov 6, 2026
- 424B3 · Shelf registrationNov 6, 2026
- 8-K · AcquisitionNov 4, 2026
- DEF 14A · Stock splitOct 30, 2026
- 424B3 · Delisting noticeOct 26, 2026
- 8-K · Delisting noticeOct 23, 2026
- SCHEDULE 13G/A · SEC filingOct 16, 2026
- 424B3 · Stock splitOct 16, 2026
- 8-K · Stock splitOct 16, 2026
Get alerts when MDCX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days